Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
The National Pharmaceutical Council (NPC) today announced that Michael L. Ryan, PharmD, Senior Vice President, Worldwide Value, Access, Pricing and...
The National Pharmaceutical Council (NPC) today announced the appointment of Robert Dubois, MD, PhD, as its interim president and CEO. The NPC Board...
The National Pharmaceutical Council (NPC) today announced that Dan Leonard will be stepping down as president and CEO, effective September 4. "Under...
The National Pharmaceutical Council (NPC) today announced that Blasine Penkowski, MBA, Chief Strategic Customer Officer of Johnson & Johnson Health...
The National Pharmaceutical Council (NPC) and Discern Health today released a study that analyzes the landscape of available patient-reported...
The National Pharmaceutical Council (NPC) today announced that Richard H. Bagger, Executive Vice President, Corporate Affairs and Market Access,...
The National Pharmaceutical Council (NPC) and Duke University's Robert J. Margolis, MD, Center for Health Policy today announced that Taruja...
A new study published in the July issue of Health Affairs shows that insurance coverage and reimbursement for specialty medications varies...
The National Pharmaceutical Council, a health policy research organization based in Washington, DC, today welcomed four biopharmaceutical companies...
The National Pharmaceutical Council today launched Going Below the Surface—a new research-first initiative intended to engage stakeholders across the ...
The National Pharmaceutical Council (NPC) today announced that Mark J. Nagy, Vice President, Global Patient Outcomes and Real World Evidence, Eli...
According to a new study conducted by Benfield, a division of Gallagher Benefit Services, on behalf of the National Pharmaceutical Council (NPC),...
The use of medications is an important part of helping accountable care organizations (ACOs) meet quality measures and improve patient outcomes, but...
The National Pharmaceutical Council and Discern Health today released a white paper analyzing the gaps in accountable care quality measure sets for...
The National Pharmaceutical Council (NPC) today announced that Ipsen Biopharmaceuticals, Inc. has joined the health policy research organization as...
Patients who have the same condition sometimes pay different out-of-pocket costs for their medications, but when is this differential fair? Payers,...
Gaps in the quality measures used by accountable care programs to assess cancer care may obscure problems in care delivery and lead to missed...
The National Pharmaceutical Council (NPC) Board of Directors today elected Joshua Ofman, MD, MSHS, Senior Vice President of Global Value, Access &...
The National Pharmaceutical Council (NPC) today welcomed EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S....
A post published today on the Health Affairs Blog brings to light the importance in reducing low value health care in the United States. According to ...
The National Pharmaceutical Council (NPC) will bring together health care stakeholders on September 29 for a conference, "Assessing Value: Promise...
The National Pharmaceutical Council (NPC), in conjunction with the Leonard D. Schaeffer Center for Health Policy & Economics at the University of...
The National Pharmaceutical Council (NPC) today announced that Mallinckrodt Pharmaceuticals has joined the health policy research organization as its ...
The National Pharmaceutical Council (NPC) today released the results of its annual survey of stakeholder views on comparative effectiveness research...
A new, peer-reviewed study examining care pathways found both strengths and areas of concern surrounding the current development and implementation...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.